Saliva Collection Devices Market Offers Promising Growth due to Increasing Adoption of Saliva-based Diagnostic Tests
The saliva collection devices market is witnessing rising demand driven by growing adoption of saliva-based diagnostic tests for disease screening and detection. Saliva collection devices aid in collecting saliva samples for further testing and analysis. Saliva sample collection is a non-invasive procedure and provides a cost-effective alternative to traditional blood collection methods. Saliva collection devices allow for easy, quick, and painless collection of saliva samples at home or in clinical settings. Key advantages include convenience, improved patient compliance, and reduced biopsy needs.
The global saliva collection devices market is estimated to be valued at US$
342.46 billion in 2024 and is expected to exhibit a CAGR of 10% over the forecast period of 2024 to 2030.
The
growth can be attributed to the rising preference for non-invasive collection
methods and surge in application of saliva-based screening across various
disease indications.
Key Takeaways
Key players operating in the saliva
collection devices market size are IBM Corporation, Oracle Corporation,
Cerner Corporation, InterSystems Corporation, Allscripts Healthcare Solutions,
Red Hat, Inc. (acquired by IBM), Microsoft Corporation, GE Healthcare, Infor,
Inc., Epic Systems Corporation, TIBCO Software Inc., McKesson Corporation, Dell
Technologies, Informatica Corporation, Ascom Holding AG. These players are
focusing on new product launches and strategic collaborations to strengthen
their market position.
The key opportunities in the market include growing demand for homecare testing
due to pandemic, increasing utilization of multi-omics techniques for in-depth
disease profiling, and use of artificial intelligence for automated sample
collection and testing. Rising focus on global expansion through partnerships
with regional diagnostic laboratories and healthcare providers is also boosting
the market growth.
In terms of geography, North America dominates the global saliva collection
devices market owing to advanced healthcare infrastructure and rising adoption
of direct-to-consumer testing. However, Asia Pacific is anticipated to witness
highest growth due to growing healthcare expenditure, increasing disease
burden, and focus toward minimally invasive diagnostic procedures.
Market Drivers
The key driver for saliva collection devices market is the increasing
adoption of saliva-based testing over blood sampling due to advantages such as
non-invasive nature, ease of collection, and painless procedure. This is
boosting the demand for saliva collection kits and containers. The market is
also driven by rising prevalence of chronic diseases necessitating regular
screening as well as integration of advanced technologies in sampling devices.
Market Restraints
The major restraint for saliva collection devices market is the low
sensitivity and specificity of certain saliva tests as compared to blood-based
counterparts. Challenges in standardization of collection and analytic
procedures also hamper market growth. Additional concerns regarding sample
preservation and storage stability impede wider commercialization of
saliva-based assays. Striking a balance between cost, accuracy, and
user-friendliness remains a challenge.
Segment Analysis
The Saliva Collection Devices Market is dominated by
two sub segments, namely, Saliva collector devices and saliva nucleic
acid/biological fluid collector devices. The saliva collector devices sub
segment holds the highest market share as these devices are easy to use and
non-invasive way to collect saliva samples for various diagnostic purposes like
hormone level analysis, cortisol level detection etc. These devices do not
require specialized skills to collect saliva samples as compared to blood
collection which requires trained professionals.
Global Analysis
Regionally, North America holds the largest share in the Saliva Collection
Devices Market owing to increased support for research and development
activities by public and private organizations for novel disease diagnostic
solutions. Asia Pacific is expected to witness the fastest growth during the
forecast period owing to rising healthcare expenditure, increasing awareness
about non-invasive sample collection methods and growing focus of international
players to tap opportunities in emerging nations in this region.
Comments
Post a Comment